We are studying a new treatment called tabelecleucel for individuals with Epstein-Barr virus-associated diseases. The goal is to see if it can improve health outcomes compared to current options.
Health conditions and diseases that the clinical trial is designed to study and treat.
EBV-related lymphoproliferative disorders are conditions caused by the Epstein-Barr virus, leading to the abnormal growth of lymphocytes (a type of white blood cell). These disorders can occur in individuals with weakened immune systems and may present as various types of tumors or lymphoproliferative diseases.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
